Article Details

UPDATE 1-CureVac COVID-19 vaccine records only 48% efficacy in final trial readout

Retrieved on: 2024-07-21 20:56:07

Tags for this article:

Click the tags to see associated articles and topics

UPDATE 1-CureVac COVID-19 vaccine records only 48% efficacy in final trial readout. View article details on hiswai:

Excerpt

CureVac said its COVID-19 vaccine was 48% effective in the final analysis of its pivotal mass trial, only marginally better than the 47% reported ...

Article found on: ca.sports.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo